Stock Events

Stock Events

Sihuan Pharmaceutical Group 

€0.15
5
-€0-1.94% Friday 06:05

Statistics

Day High
0.17
Day Low
0.17
52W High
0.21
52W Low
0.06
Volume
-
Avg. Volume
-
Mkt Cap
1.42B
P/E Ratio
0
Dividend Yield
1.58%
Dividend
0

Upcoming

30
JUN
Dividend Ex
Increased
 
16
JUL
Dividend Payment
Increased
 
28
SEP
Dividend Ex
Estimated
 
9
OCT
Dividend Payment
Estimated
 
30
JUN 27
Dividend Ex
Estimated
 

Dividends

1.58%Dividend Yield
Oct 25
€0
Oct 24
€0
Jun 23
€0
Oct 22
€0
Oct 22
€0
10Y Growth
-17.07%
5Y Growth
-7.17%
3Y Growth
-35.25%
1Y Growth
N/A

Earnings

31MarExpected
Q4 2020
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0
0
0
0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-11.46%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
499.66MRevenue
-57.24MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TEL1.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that competes in various pharmaceutical sectors, including areas where Sihuan Pharmaceutical operates.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a large pharmaceutical company with a broad range of products that compete in the same market segments as Sihuan Pharmaceutical.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that offers products in multiple areas, including those where Sihuan Pharmaceutical is active, making it a direct competitor.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a leading pharmaceutical company with a diverse product portfolio that competes with Sihuan Pharmaceutical's offerings.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson is a healthcare giant that operates in various pharmaceutical niches, competing with Sihuan Pharmaceutical across several product lines.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global pharmaceutical company with a wide range of products that compete with Sihuan Pharmaceutical, especially in the areas of cardiovascular and metabolic diseases.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie is a research-based biopharmaceutical company with a strong presence in areas like immunology and oncology, competing with Sihuan Pharmaceutical.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with products that compete in the same therapeutic areas as Sihuan Pharmaceutical.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with Sihuan Pharmaceutical.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with Sihuan Pharmaceutical in several key areas.

About

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
Show more...
CEO
Dr. Fengsheng Che
Employees
2767
Country
DE
ISIN
BMG8162K1137
WKN
000A1C72G

Listings

STU
DE
TEL1.STU
OTC Link
US
SHPHY
F
DE
TEL1.F
OTC Link
US
SHPHF

0 Comments

Share your thoughts

FAQ

What is Sihuan Pharmaceutical Group stock price today?▼
The current price of TEL1.F is €0.15 EUR — it has decreased by -1.94% in the past 24 hours. Watch Sihuan Pharmaceutical Group stock price performance more closely on the chart.
What is Sihuan Pharmaceutical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sihuan Pharmaceutical Group stocks are traded under the ticker TEL1.F.
Is Sihuan Pharmaceutical Group stock price growing?▼
TEL1.F stock has risen by +0% compared to the previous week, the month change is a -5.59% fall, over the last year Sihuan Pharmaceutical Group has showed a +123.53% increase.
What is Sihuan Pharmaceutical Group market cap?▼
Today Sihuan Pharmaceutical Group has the market capitalization of 1.42B
When is the next Sihuan Pharmaceutical Group earnings date?▼
Sihuan Pharmaceutical Group is going to release the next earnings report on September 01, 2026.
What is Sihuan Pharmaceutical Group revenue for the last year?▼
Sihuan Pharmaceutical Group revenue for the last year amounts to 499.66M EUR.
What is Sihuan Pharmaceutical Group net income for the last year?▼
TEL1.F net income for the last year is -57.24M EUR.
Does Sihuan Pharmaceutical Group pay dividends?▼
Yes, TEL1.F dividends are paid semi-annual. The last dividend per share was 0 EUR. As of today, Dividend Yield (FWD)% is 1.58%.
How many employees does Sihuan Pharmaceutical Group have?▼
As of April 11, 2026, the company has 2,767 employees.
In which sector is Sihuan Pharmaceutical Group located?▼
Sihuan Pharmaceutical Group operates in the Health Care sector.
When did Sihuan Pharmaceutical Group complete a stock split?▼
The last stock split for Sihuan Pharmaceutical Group was on June 05, 2014 with a ratio of 2:1.
Where is Sihuan Pharmaceutical Group headquartered?▼
Sihuan Pharmaceutical Group is headquartered in Wan Chai, DE.